Skip to main content
Search
Home    /    Insights & Resources

Insights & Resources

Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.

Explore Q3 2025 trends in Texas life sciences, from Series B collapse and pipeline bottlenecks to sector divergence and record late-stage capital.
Life sciences companies often overlook SOX in IPO prep. Discover how early action and targeted strategies can strengthen investor confidence.
The SEC’s new regulations for safeguarding crypto assets and the administration’s executive order are changing the landscape for digital assets.
J.P. Morgan’s Q3 2024 Biopharma Report highlights robust venture investments, shifting licensing trends and a resurgence in IPO activity.
The Q3 2024 Medtech Report from J.P. Morgan spotlights heightened investments, mergers and public offerings, signaling a positive industry outlook.
The home health and hospice sectors are facing significant challenges with personal care emerging as the key sector for mitigating risk.
Boards and management should examine how traditional and emerging risks, especially generative AI and other new technology, may affect their operations.
Weaver offers several topics to incorporate into the discussions at your next board and committee meetings. Consider these questions for your upcoming board meeting.
As the SEC considers regulations to strengthen cybersecurity in public companies, concerns about cyberattacks are on the rise. Learn more.
To improve cyber resiliency in the financial sector, the Securities and Exchange Commission (SEC) recently proposed amendments to existing regulation of the technology infrastructure in U.S. securities markets.
Is your company considering undertaking an ESG reporting program? Weaver provides helpful information as to what other companies are doing.